Literature DB >> 2027360

Heparin.

J Hirsh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027360     DOI: 10.1056/NEJM199105303242206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  137 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable Angina.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  Six blind men and the elephant--the many faces of heparan sulfate.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.

Authors:  A P Schroeder; L L Knudsen; S E Husted; L Knudsen; J Ingerslev
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

6.  Fusion of two distinct peptide exosite inhibitors of Factor VIIa.

Authors:  Martin Roberge; Mark Peek; Daniel Kirchhofer; Mark S Dennis; Robert A Lazarus
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

Review 7.  New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.

Authors:  Walter Ageno; Alexander G G Turpie
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

Review 8.  A guide to drug use during percutaneous coronary intervention.

Authors:  Joseph K Choo; John J Young; Dean J Kereiakes
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Absence of drug interaction between temafloxacin and low dose heparin.

Authors:  T Mant; P Morrison; E Millar
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

Review 10.  Enoxaparin. A review of its clinical potential in the management of coronary artery disease.

Authors:  S Noble; C M Spencer
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.